Protect Animal Health
寶泰生醫股份有限公司
Protect Animal Health is a Taiwan Emerging Stock Board biotechnology company; its most advanced asset is PT001 (Clinical trial authorized, Canine tumors), as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| PT001 | — | Clinical trial authorized | Canine tumors | Hungary | 2026-10-05 | Company disclosure |
| PT401 | — | Clinical trial authorized | Canine myxomatous mitral valve disease | Thailand | 2026-06-09 | Company disclosure |
Key events
- Protect Animal Health and Bora Biologics announced a multi-project development and manufacturing collaboration (company disclosure)
- PT401 gene-therapy partnership update (company disclosure)
- PT001 canine melanoma vaccine field trial authorized in Taiwan (company disclosure)